SCHEMBL21569047

SCHEMBL21569047

CN(C)C/C=C/C(=O)Nc1c(O[C@H]2CCOC2)ccc2c(Nc3ccc(OCc4ccccc4F)c(Cl)c3)c(C#N)cnc12

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 20/20 0.64
▸ ERBB2 P04626 17/20 0.64
▸ SRC P12931 2/20 0.54
▸ KDR P35968 1/20 0.54
▸ CIT O14578 1/20 0.53
▸ GAK O14976 1/20 0.53
▸ EPHB6 O15197 1/20 0.53
▸ RIPK2 O43353 1/20 0.53
▸ STK10 O94804 1/20 0.53
▸ ABL1 P00519 1/20 0.53
▸ LCK P06239 1/20 0.53
▸ LYN P07948 1/20 0.53
▸ RET P07949 1/20 0.53
▸ CHRM2 P08172 1/20 0.53
▸ MET P08581 1/20 0.53
▸ HCK P08631 1/20 0.53
▸ PHKG2 P15735 1/20 0.53
▸ ADRA2B P18089 1/20 0.53
▸ ERBB3 P21860 1/20 0.53
▸ AXL P30530 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21569069 1.00 EGFR (0.64) EGFRERBB2SRCKDRCIT
SCHEMBL21569014 0.95 EGFR (0.59) EGFRERBB2SRCKDRGAK
SCHEMBL21569098 0.95 EGFR (0.59) EGFRERBB2SRCKDRGAK
SCHEMBL21569116 0.95 EGFR (0.64) EGFRERBB2SRCKDRGAK
SCHEMBL21569020 0.95 EGFR (0.64) EGFRERBB2SRCKDRGAK
SCHEMBL21569000 0.94 EGFR (0.58) EGFRERBB2SRCKDRGAK
SCHEMBL21568993 0.94 EGFR (0.58) EGFRERBB2SRCKDRGAK
SCHEMBL21569002 0.92 EGFR (0.65) EGFRERBB2SRCKDR
SCHEMBL21569011 0.92 EGFR (0.65) EGFRERBB2SRCKDR
SCHEMBL21569052 0.91 EGFR (0.62) EGFRERBB2SRCKDRCIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3222620-B1 CYANOQUINOLINE DERIVATIVES TIANJIN HEMAY ONCOLOGY PHARMACEUTICAL CO LTD (CN) 2019-11-20 — — EP claimed
Send feedback